EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 10 (Octobre 2021) Med Sci (Paris), 37 10 (2021) 882-887 Références
Contraception
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 10, Octobre 2021
Contraception
Page(s) 882 - 887
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2021147
Publié en ligne 14 octobre 2021
  1. Santé publique France. Étude ESTEBAN 2014–2016 – Chapitre corpulence : stabilisation du surpoids et de l’obésité chez l’enfant et l’adulte. https://www.santepubliquefrance.fr/les-actualites/2017/etude-esteban-2014-2016-chapitre-corpulence-stabilisation-du-surpoids-et-de-l-obesite-chez-l-enfant-et-l-adulte. [Google Scholar]
  2. Bajos N, Wellings K, Laborde Cet al. Sexuality and obesity, a gender perspective : results from French national random probability survey of sexual behaviours. BMJ 2010 ; 340 : c2573. [PubMed] [Google Scholar]
  3. Brill MJ, Diepstraten J, van Rongen Aet al. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet 2012 ; 51 : 277–304. [PubMed] [Google Scholar]
  4. Hanley MJ, Abernethy DR, Greenblatt DJEffect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 2010 ; 49 : 71–87. [PubMed] [Google Scholar]
  5. Ciangura C, Bouillot JL, Lloret-Linares Cet al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity 2010 ; 18 : 760–765. [Google Scholar]
  6. Chumlea WC, Guo SS, Zeller CMet al. Total body water reference values and prediction equations for adults. Kidney Int 2001 ; 59 : 2250–2258. [PubMed] [Google Scholar]
  7. Poirier P, Giles TD, Bray GAet al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss : an update of the 1997 American heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 2006 ; 113 : 898–918. [PubMed] [Google Scholar]
  8. Edholm D, Kullberg J, Haenni Aet al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg 2011 ; 21 : 345–350. [PubMed] [Google Scholar]
  9. Ribstein J, du Cailar G, Mimran ACombined renal effects of overweight and hypertension. Hypertension 1995 ; 26 : 610–615. [PubMed] [Google Scholar]
  10. Valensi P, Assayag M, Busby Met al. Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord 1996 ; 20 : 574–579. [PubMed] [Google Scholar]
  11. Fabbrini E, Sullivan S, Klein SObesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010 ; 51 : 679–689. [PubMed] [Google Scholar]
  12. Lumeng CN, Saltiel ARInflammatory links between obesity and metabolic disease. J Clin Invest 2011 ; 121 : 2111–2117. [PubMed] [Google Scholar]
  13. Tilg H, Kaser AGut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011 ; 121 : 2126–2132. [PubMed] [Google Scholar]
  14. Westhoff CL, Torgal AH, Mayeda ERet al. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception 2010 ; 81 : 474–480. [PubMed] [Google Scholar]
  15. Westhoff CL, Torgal AH, Mayeda ERet al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol 2010 ; 116 : 275–283. [PubMed] [Google Scholar]
  16. Luo D, Westhoff CL, Edelman ABet al. Altered pharmacokinetics of combined oral contraceptives in obesity – multistudy assessment. Contraception. 2019 ; 99 : 256–263. [PubMed] [Google Scholar]
  17. Westhoff CL, Reinecke I, Bangerter K, Merz MImpact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene : a multicenter, open-label, uncontrolled study over three treatment cycles. Contraception 2014 ; 90 : 272–279. [PubMed] [Google Scholar]
  18. Westhoff CL, Torgal AH, Mayeda ER, et al. Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women. Am J Obstet Gynecol 2012; 207 : 39.e1-6. [Google Scholar]
  19. Grimes DA, Shields WCFamily planning for obese women: challenges and opportunities. Contraception 2005 ; 72 : 1–4. [PubMed] [Google Scholar]
  20. Trussell J, Schwarz EB, Guthrie KObesity and oral contraceptive pill failure. Contraception 2009 ; 79 : 334–338. [PubMed] [Google Scholar]
  21. Holt VL, Cushing-Haugen KL, Daling JRBody weight and risk of oral contraceptive failure. Obstet Gynecol 2002 ; 99 : 820–827. [PubMed] [Google Scholar]
  22. Trussell J, Schwarz EB, Guthrie KObesity and oral contraceptive pill failure. Contraception 2009 ; 79 : 334–338. [PubMed] [Google Scholar]
  23. Holt VL, Scholes D, Wicklund KGet al. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005 ; 105 : 46–52. [PubMed] [Google Scholar]
  24. Lopez LM, Bernholc A, Chen M, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2016; CD008452. [PubMed] [Google Scholar]
  25. Zieman M, Guillebaud J, Weisberg Eet al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002 ; 77 : S13–S18. [PubMed] [Google Scholar]
  26. Huber J, Wenzl RPharmacokinetics of Implanon. An integrated analysis. Contraception 1998 ; 58 : S85–S90. [Google Scholar]
  27. Xu H, Wade JA, Peipert JFet al. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol 2012 ; 120 : 21–26. [PubMed] [Google Scholar]
  28. Robinson JA, Burke AEObesity and hormonal contraceptive efficacy. Womens Health (Lond) 2013 ; 9 : 453–466. [PubMed] [Google Scholar]
  29. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1995; 346 : 1582–8. [PubMed] [Google Scholar]
  30. Pomp ER, le, CS, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007 ; 139 : 289–296. [PubMed] [Google Scholar]
  31. Skeith L, Le Gal G, Rodger MA. contraceptives and hormone replacement therapy : How strong a risk factor for venous thromboembolism? Thromb Res Oral 2021; 202 : 134–8. [Google Scholar]
  32. Tanis BC, van den Bosch MA, Kemmeren JMet al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001 ; 345 : 1787–1793. [PubMed] [Google Scholar]
  33. WHO. Medical eligibility criteria for contraceptive use. A WHO family planning cornerstone, 5e ed. Geneva : World Health Organization, 2015. [Google Scholar]
  34. Ciangura C, Coupaye M, Deruelle Pet al. Clinical practice guidelines for childbearing female candidates for bariatric surgery, pregnancy, and post-partum management after bariatric surgery. Obes Surg 2019 ; 29 : 3722–3734. [PubMed] [Google Scholar]
  35. Sjöström L.Review of the key results from the Swedish obese subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 2013 ; 273 : 219–234. [PubMed] [Google Scholar]
  36. Thereaux J, Veyrie N, Barsamian Cet al. Similar postoperative safety between primary and revisional gastric bypass for failed gastric banding. JAMA Surg 2014 ; 149 : 780–786. [PubMed] [Google Scholar]
  37. Ciangura C, Bouillot JL, Lloret-Linares Cet al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity 2010 ; 18 : 760–765. [Google Scholar]
  38. Padwal R, Brocks D, Sharma AMA systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 2010 ; 11 : 41–50. [PubMed] [Google Scholar]
  39. Padwal RS, Ben-Eltriki M, Wang Xet al. Effect of gastric bypass surgery on azithromycin oral bioavailability. J Antimicrob Chemother 2012 ; 67 : 2203–2206. [PubMed] [Google Scholar]
  40. Padwal RS, Gabr RQ, Sharma AMet al. Effect of gastric bypass surgery on the absorption and bioavailability of metformin. Diabetes Care 2011 ; 34 : 1295–1300. [PubMed] [Google Scholar]
  41. Hamad GG, Helsel JC, Perel JMet al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry 2012 ; 169 : 256–263. [PubMed] [Google Scholar]
  42. Angeles PC, Robertsen I, Seeberg LTet al. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: a systematic review. J Obes Rev 2019 ; 20 : 1299–1311. [Google Scholar]
  43. Ciangura C, Corigliano N, Basdevant Aet al. Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports. Contraception 2011 ; 84 : 649–651. [PubMed] [Google Scholar]
  44. Moreira de Brito C, de Melo ME, Mancini MC, et al. Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis 2021; 17 : 673–81. [PubMed] [Google Scholar]
  45. Ginstman C, Frisk J, Carlsson Bet al. Plasma concentrations of etonogestrel in women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study. BJOG 2019 ; 126 : 486–492. [PubMed] [Google Scholar]
  46. Madden S, Back DJ, Martin CA, Orme MLMetabolism of the contraceptive steroid desogestrel by the intestinal mucosa. Br J Clin Pharmacol 1989 ; 27 : 295–299. [PubMed] [Google Scholar]
  47. Chabbert-Buffet N, Marret H, Agostini Aet al. Clinical practice guidelines for contraception by the French national college of gynecologists and obstetricians (CNGOF). J Gynecol Obstet Hum Reprod 2019 ; 48 : 441–454. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.